Centene vs HealthEquity
Centene reported revenue of $194.8 billion in fiscal 2025, 148.3 times HealthEquity's $1.3 billion in fiscal 2026. Centene's revenue grew 19.4% in its latest year, and HealthEquity's grew 9.5%. Centene had an operating margin of -3.9%, against 24.6% at HealthEquity. Free cash flow was $4.3 billion at Centene and $455 million at HealthEquity. Their fiscal years end in different months (December 31 and January 31), so the periods don't line up exactly.
Side by side
| Centene | HealthEquity | |
|---|---|---|
| Latest fiscal year | FY2025, Dec 31, 2025 | FY2026, Jan 31, 2026 |
| Revenue | $194.8B | $1.3B |
| Revenue growth | 19.4% | 9.5% |
| Revenue growth a year, last 5 years | 11.9% | 12.4% |
| Gross margin | — | 69.5% |
| Operating margin | −3.9% | 24.6% |
| Net margin | −3.4% | 16.4% |
| Free cash flow | $4.3B | $455M |
| Free cash flow margin | 2.2% | 34.6% |
| Return on capital | −26.4% | 8.9% |
| Net debt to EBITDA | — | 1.3x |
| Dividends and buybacks | $475M | $299M |
| Change in diluted share count | −5.8% | −1.5% |
| Last close | $68.03 | $103.75 |
| P/E at the last close | — | 37.5× |
| Insider trades, last 12 months | sold $14.6 million | bought $11,942, sold $4.2 million |
| Piotroski F-score | 5 of 8 | 9 of 9 |
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.
Ten years
Revenue
US$ billions, fiscal years
CenteneHealthEquity
Operating margin
Percent of revenue
CenteneHealthEquity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
CenteneHealthEquity
Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Centene and HealthEquity pages.